SCHEDULE: Karpus Management Discloses 1.28% Stake in Aimei Health

Karpus Management, Inc. reported a 1.28% beneficial ownership stake in Aimei Health Technology Co., Ltd. as of December 31, 2025.

Summary

• Karpus Management, Inc., a registered investment adviser, beneficially owns 78,075.00 shares of Common stock in Aimei Health Technology Co., Ltd.
• This ownership represents 1.28% of the class of securities.
• Karpus Management, Inc. holds sole voting power and sole dispositive power over all 78,075.00 shares.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of the issuer.
• Karpus Management, Inc. is controlled by City of London Investment Group plc (CLIG), but maintains effective informational barriers, exercising independent voting and investment power.

Sentiment

Score: 5

Explanation: A Schedule 13G filing is a routine disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the issuer's performance or prospects.

Management Comments

• Karpus Management, Inc. certified that the securities were acquired and are held in the ordinary course of business, not for the purpose of or with the effect of changing or influencing the control of Aimei Health Technology Co., Ltd.

Stakeholder Impact

• Provides transparency to shareholders and the market regarding significant ownership stakes, confirming Karpus Management's passive investment intent.

Key Dates

Keywords

Aimei Health Technology, Karpus Management, Beneficial Ownership, Schedule 13G, Investment Management, Common Stock